J Korean Acad Rehabil Med.  2006 Apr;30(2):111-115.

The Efficacy of Donepezil on Cognitive Dysfunction in Subacute Post-stroke Patients

Affiliations
  • 1Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Korea. graceloves@medimail.co.kr

Abstract


OBJECTIVE
To evaluate the efficacy of donepezil on cognitive dysfunction in subacute post-stroke patients. METHOD: Sixty subacute stroke subjects were enrolled and randomly assigned into an experimental or control group. There was no significant difference between the two groups in age, sex and post-onset duration. Donepezil 5 mg was administered daily for 6 weeks to patients in the experimental group. Mini-Mental Status Examination (MMSE), Wechsler Memory Test (WMT) and Colored Progressive Matrices (CPM) were performed before and 6 weeks after administration of the study drug in both groups.
RESULTS
There was no difference between the two groups in the MMSE, WMT, CPM scores at baseline. Six weeks later, the total score, memory input, recall and judgement as measured by the MMSE and the score on the WMT were significantly more improved in the experimental group when compared to the control group (p<0.05). However, there was no significant difference between the two groups on the CPM score.
CONCLUSION
These results suggested that donepezil may be helpful for improving cognitive function, especially memory in post-stroke patients.

Keyword

Donepezil; Cognitive function; Memory; Stroke

MeSH Terms

Humans
Memory
Stroke
Full Text Links
  • JKARM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr